MOH Options Flip Bullish Days Before the Print

Molina Healthcare, a government-sponsored managed care insurer serving roughly 5 million Medicaid and marketplace members across 21 states, reports third-quarter results today with its options market telling a strikingly different story from where it stood just two weeks ago.

The sharpest shift has been in options positioning. The put/call ratio has dropped to 0.77, nearly two and a half standard deviations below its 20-day average of 1.16. For six consecutive weeks through mid-October, the ratio sat in a tight band around 1.24, reflecting steady demand for downside protection. That posture unwound sharply from October 19 onward. The current reading is the lowest of the past 52 weeks, against a full-year low of 0.74, meaning call buyers now dominate to a degree the stock has not seen all year. The borrow market reinforces the picture: availability remains near the practical ceiling, with roughly 100 shares available to lend for every one currently borrowed, and borrowing costs are low at 0.46%. Short interest has pulled back about 8% over the past month to 5.5% of the free float.

The analyst community is more cautious. A consensus of 15 hold ratings and no outperforms reflects an industry group under pressure, and recent target cuts from Wells Fargo, Truist, RBC and Barclays following the July quarterly report all landed well above the current price of $214.90, but they came with maintained neutral or underweight stances. The bear case centres on structural fragility: more than 85% of members are in Medicaid, leaving earnings exposed to state funding decisions, and management trimmed its embedded earnings backlog estimate from above $11 per share at the May investor day to $9. Marketplace weakness, a 2026 Medicaid rate environment modelled at 4% against roughly 5% cost trend, and potential membership attrition tied to OBBBA changes compound the pressure. The bull case points to the 2029 management framework of $64 billion in premium revenue, meaningful AI-driven cost savings, and a structural opportunity in the dual-eligibles market where Molina holds only 6% share in geographies where its Medicaid presence is 16%. EPS momentum is running in the 86th and 91st percentile on 30-day and 90-day horizons respectively, and 12-month forward EPS growth estimates rank in the 98th percentile of the universe.

The stock has recovered 7% over the past month to $214.90, though it shed 2.2% on Wednesday. Peers CNC, ELV and UNH each gained between 2.3% and 3.5% on the day MOH fell, a mild divergence worth noting ahead of the release. The prior two earnings events, both in July, produced one-day declines of roughly 11% that extended to around 12% over the following five days. BlackRock has been a notable accumulator, lifting its stake from 6.9% to 11.7% based on its most recent 13G filing, while T. Rowe Price has moved the other direction, trimming from 6.5% to 1.9%.

The print will test whether the Q3 Medicaid rate environment has closed the gap against cost trends, and whether management can offer enough clarity on 2027 membership to justify the call-side positioning that has built so rapidly in the final days before the release.